Skip to content

Effect of WeChat follow-up on the recurrence rate of ischemic stroke patients

Effect of WeChat follow-up on the recurrence rate of ischemic stroke patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029590
Enrollment
Unknown
Registered
2020-02-05
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral ischemic stroke

Interventions

WeChat follow-up group:Follow-up will be performed with WeChat
Routine follow-up group:Follow up as usual

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. It met the diagnostic criteria of "guidelines for the diagnosis and treatment of acute ischemic stroke in China 2018", and was confirmed as ischemic stroke by head CT/MRI; 2. First onset of the patient, within 30 days; 3. Aged between 18 and 80; 4. The patient has clear consciousness and no obvious cognitive impairment; 5. The patient or his/her family has registered a WeChat account and has the ability to use WeChat for communication; 6. The patient or his/her family agrees to accept this study and cooperate with the collection of relevant information.

Exclusion criteria

Exclusion criteria: 1. Cerebral embolism; 2. Severe cardiopulmonary dysfunction,hepatorenal dysfunction , serious malignant diseases (malignant tumors), pernicious anemia, etc.; 3. Participated in other clinical trials recently or unwilling to accept this study.

Design outcomes

Primary

MeasureTime frame
The recurrence rate of ischemic stroke during the follow-up period;

Countries

China

Contacts

Public ContactWen Han

The First Affiliated Hospital of Nanchang University

wh15770765360@163.com+86 15770765360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026